Modafinil for Excessive Daytime Sleepiness in Narcolepsy: A Meta-Analysis

This systematic review and meta-analysis evaluates the effectiveness of modafinil in managing excessive daytime sleepiness associated with narcolepsy. By synthesizing data from multiple clinical trials, the researchers confirmed that the drug significantly improves objective wakefulness and reduces subjective drowsiness compared to placebos. The authors note that while modafinil is a first-line stimulant with a lower risk of abuse than amphetamines, it does not effectively treat cataplexy. A primary finding of the report is the lack of recent randomized controlled trials, as most foundational evidence stems from studies conducted over a decade ago. Consequently, the paper underscores a critical need for new, long-term research to better establish the medication's extended safety and comparative performance against newer therapies. Overall, the text reinforces modafinil's role in improving patient quality of life while identifying significant gaps in contemporary clinical data.